Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Viromed Medical: board member buys 11,300 shares via XETRA

Board member Uwe Perbandt reported purchases of a total of 11,300 Viromed Medical shares on 4 September 2026 via XETRA. The transactions were executed at individual prices of 5.60 EUR and 5.70 EUR, with an aggregate volume of 11,300 shares at an average price of 5.65 EUR. The transaction was publicly reported in accordance with statutory transparency obligations. » Plus sur de.investing.com
Viromed Medical: executive board member sells 80,000 shares, stock falls after disclosure

Executive board member Perbandt, Uwe, sold a total of 80,000 Viromed Medical shares at €6.95 each on 25 August 2026; the transaction was reported on 28 August 2026. After the announcement the share fell sharply in FSE trading, at times trading between €6.30 and €6.80. Viromed Medical currently has a market value of around €129.60 million with 20,250,000 tradable shares; prior to that a closely connected person sold 7,500 shares at €7.05 on 24 August 2026. » Plus sur finanzen.net
Viromed Medical executive Perbandt sells shares in August

Heike Perbandt sold a total of 7,500 Viromed Medical shares at €7.05 each on 24 August 2026; previously she had already disposed of 10,000 shares at €7.10 each on 20 August 2026. The stock reacted with losses and traded on the FSE around the day of the disclosure between €6.80 and €6.85. Viromed Medical’s market capitalization currently stands at around €142.76 million, and 20,250,000 shares are tradable. » Plus sur finanzen.net